Viewing Study NCT01220934


Ignite Creation Date: 2025-12-25 @ 2:29 AM
Ignite Modification Date: 2026-01-08 @ 9:19 AM
Study NCT ID: NCT01220934
Status: COMPLETED
Last Update Posted: 2018-06-20
First Post: 2010-09-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Observational Study of Herceptin (Trastuzumab) in Patients With HER2-positive Advanced Gastric Cancer
Sponsor: Hoffmann-La Roche
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module